Novel Approach to Treat Insulin Resistance, Type 2 Diabetes, and the Metabolic Syndrome: Simultaneous Activation of PPAR, PPAR&ggr;, and PPAR&dgr;

Publisher： Bentham Science Publishers

E-ISSN： 1875-6417|1|3|299-307

ISSN： 1573-3998

Source： Current Diabetes Reviews, Vol.1, Iss.3, 2005-11, pp. : 299-307

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Thiazolidinediones as PPAR&ggr; Ligands with the Potential for the Prevention of Cardiovascular Disease in Diabetes

By  

Current Diabetes Reviews, Vol. 2, Iss. 2, 2006-05 ,pp. : 227-239

Bentham Science Publishers

Access to resources Recommend Favorite

PPAR&ggr; Agonists: Beneficial Effect on Blood Pressure Beyond Glycemic Control?

By  

Current Hypertension Reviews, Vol. 2, Iss. 1, 2006-02 ,pp. : 47-60

Bentham Science Publishers

Access to resources Recommend Favorite

PPAR and the Treatment of Insulin Resistance

By Olefsky J.M.   Saltiel A.R.  

Trends in Endocrinology and Metabolism, Vol. 11, Iss. 9, 2000-11 ,pp. : 362-368

Elsevier

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR) in Metabolic Syndrome and Type 2 Diabetes Mellitus

By  

Current Diabetes Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 33-39

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Prostaglandin (PG) and Peroxisome Proliferator-Activated Gamma (PPAR &ggr; ) in Pulmonary Fibrosis

By  

Current Respiratory Medicine Reviews, Vol. 5, Iss. 1, 2009-02 ,pp. : 3-5

Bentham Science Publishers

Access to resources Recommend Favorite